Mucoadhesive Antioxidant Nanoadjuvant Delivers Enhanced Intranasal Influenza Vaccine Immunogenicity
ACS Applied Materials & Interfaces · 05.08.2026 · 18 (30) · 41621-41638
DOI: 10.1021/acsami.6c07805 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 20.07.2026. Verfasst von Jiahui Yin und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Nanjing Agricultural University, Nanjing210095, China. Hauptthemen laut MEDLINE: Influenza Vaccines, Adjuvants, Immunologic, Antioxidants, Adjuvants, Vaccine. Die Arbeit nennt 63 Literaturangaben. Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Influenza viruses remain a persistent and significant threat to global public health. However, currently available whole inactivated virus (WIV) vaccines fail to elicit robust mucosal immune responses, weakening the first line of defense against respiratory viral infection. Intranasal vaccination represents a promising strategy for achieving both mucosal and systemic immunity against influenza, but safe and highly immunostimulatory adjuvants are required for good efficacy. Here, we developed a multifunctional nanocomposite adjuvant, GO-IONPs-PEI (GIP), which was designed to enhance immunogenicity, regulate inflammatory responses, and maintain local redox homeostasis. Following intranasal coadministration with the influenza antigen, GIP nanoparticles exhibited excellent biocompatibility and effectively promoted dendritic cell maturation, likely via the active modulation of the mucosal immune microenvironment. In vivo, GIP markedly enhanced both systemic and mucosal immune responses, including the robust induction of protective mucosal IgA responses. Collectively, these findings reveal that GIP could be a promising adjuvant platform for next-generation intranasal influenza vaccines. Furthermore, the results highlight that the multifunctional modulation of the mucosal microenvironment is an effective strategy for improving the performance of WIV vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Nanjing Agricultural University, Nanjing210095, China.
- Engineering Research Center for the Prevention and Control of Animal Original Zoonosis & College of Life Science, Longyan University, Longyan364012, China.
- College of Life Sciences, Nanjing Agricultural University, Nanjing210095, P. R. China.
ORCID-Profile: Jinqiu Zhang
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Yin, J., Zhao, Y., Li, Z., Xu, Y., Wang, Z., Zhang, J., & Miao, J. (2026). Mucoadhesive Antioxidant Nanoadjuvant Delivers Enhanced Intranasal Influenza Vaccine Immunogenicity. ACS Applied Materials & Interfaces, 18(30), 41621-41638. https://doi.org/10.1021/acsami.6c07805
Vancouver
Yin J, Zhao Y, Li Z, Xu Y, Wang Z, Zhang J, et al. Mucoadhesive Antioxidant Nanoadjuvant Delivers Enhanced Intranasal Influenza Vaccine Immunogenicity. ACS Applied Materials & Interfaces. 2026;18(30):41621-41638. doi:10.1021/acsami.6c07805
BibTeX
@article{Yin2026,
author = {Yin, Jiahui and Zhao, Yanyan and Li, Zhi and Xu, Yuanyuan and Wang, Zhenglei and Zhang, Jinqiu and Miao, Jinfeng},
title = {Mucoadhesive Antioxidant Nanoadjuvant Delivers Enhanced Intranasal Influenza Vaccine Immunogenicity},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
volume = {18},
number = {30},
pages = {41621--41638},
doi = {10.1021/acsami.6c07805}
}
EUVIMED